GVK Biosciences, Excel Form Asia Alliance

GVK Biosciences, an India-based research services provider, has entered into a strategic alliance with Excel PharmaStudies, a Chinese CRO, to conduct clinical trials in Asia. Through the alliance sponsors will be able to conduct Phase II-IV trials taking advantage of India’s experience with Phase II/III trials and China’s large market, and Phase III/IV studies.

Under the terms of the agreement, GVK BIO and Excel will help sponsors conduct and manage Phase II-IV trials, statistical analysis and medical writing. Excel trials in India will be carried out by the GVK BIO clinical research team and will be managed by Excel’s core project management team. Similarly, a GVK BIO trial in China will be carried out by the Excel team and managed by GVK BIO’s project management team.

“This is a first of a kind alliance between an Indian CRO and a Chinese CRO. The alliance integrates trial management across India and China and provides sponsors with a single point of contact,” said Manni Kantipudi, president GVK BIO.

“It is an important step for Excel, and our clients, to be able to provide full services in both important countries,” said Dr. William Xiong, chief executive officer Excel PharmaStudies.